search icon
  • Print
  • ShareThis
  • Text Size

In order to contribute to the discussion forum you need to be an IDSA member. If you are an IDSA member, please login now. Please read our Discussion Forum Guidelines and Terms of Use before joining.

Hepatitis C

Welcome to Hepatitis C Management Discussion Board! The Hepatitis C Management Discussion Board provides Infectious Disease Clinicians a platform to connect with colleagues to exchange information, case studies, complications, and new developments on matters concerning hepatitis C treatment and management. Certain case studies will be developed into clinical vignettes and will be available to Infectious Disease Clinicians for future reference. Please be respectful of all participants and their respective comments. Please read our Terms of Use and Discussion Forum Guidelines.


Any diagnostic or therapeutic recommendations and all opinions presented are those of the individual contributor. They do not necessarily represent the views of IDSA. The reader assumes all risks in using this information. The IDSA Hepatitis C Discussion Forum is in full compliance with HIPPA. IDSA bears no responsibility for the accuracy of participant comments and will bear no legal liability for discussion results.

If a participant wishes to post an issue on the IDSA Hepatitis C Discussion Forum, the participant is strongly urged to provide contact information for possible offline discussion via phone or email concerning the posted issue.

RSS Feed Search Category View 
Drug Therapy
  Topics Topic Starter Replies Views Last Post
AbbVie Announces Positive Phase III Results ThomasKim 0 9227 Friday, April 11, 2014 1:52 PM 
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results 0 10475 Monday, November 18, 2013 1:45 PM 
AbbVie Submits FDA Application for All Oral HCV Therapy 0 9428 Tuesday, April 22, 2014 1:52 PM 
Bristol-Myers gains FDA breakthrough track for HCV drug approval 0 13718 Thursday, April 25, 2013 2:00 PM 
Bristol-Myers Squibb Files for FDA Approval of NS5A Drug Combination 0 9250 Thursday, April 10, 2014 1:50 PM 
Clinicians Wait for Next Wave of Hepatitis C Antivirals - By: Debra Gordon 0 12853 Tuesday, June 11, 2013 3:43 PM 
FDA Approved Changes to Incivek (telaprevir) Product Labeling to Include OPTIMIZE Trial Results 0 10800 Wednesday, October 30, 2013 7:56 AM 
FDA approves Sovaldi for chronic hepatitis C ThomasKim 0 10435 Monday, December 9, 2013 10:21 AM 
FDA Internal Review of Sofosbuvir 0 10822 Wednesday, October 23, 2013 1:21 PM 
Gilead applies for FDA approval for Sofosbuvir ThomasKim 0 13723 Tuesday, April 9, 2013 1:36 PM 
Gilead gains FDA approval for hep C combo pill ThomasKim 0 4773 Monday, October 13, 2014 12:34 PM 
Gilead Next Generation Combination Pill ThomasKim 0 9541 Monday, March 24, 2014 1:01 PM 
Gilead Passes Two Phase III Test with HCV Pill ThomasKim 0 13981 Monday, February 4, 2013 4:01 PM 
Gilead says payers feel comfortable with the cost of Sovaldi ThomasKim 0 10064 Friday, February 14, 2014 1:06 PM 
Gilead Successfully Completes Fourth Phase III Study tkim 0 13840 Tuesday, February 19, 2013 1:03 PM 
Gilead's Sofosbuvir Gains FDA Panel Approval 0 10832 Monday, October 28, 2013 1:14 PM 
Indication and Usage of Olysio (simeprevir) for the Treatment of Chronic Hepatitis C ThomasKim 0 10346 Monday, November 25, 2013 2:38 PM 
J&J wins FDA panel blessing for hep C blockbuster hopeful ThomasKim 0 10649 Friday, October 25, 2013 2:32 PM 
J&J, Gilead combo drug therapy clears hep C in 100% of Phase IIa cohort ThomasKim 0 14211 Monday, March 4, 2013 1:00 PM 
J&J, Medivir gain FDA OK for new hep C therapy simeprevir ThomasKim 0 10352 Monday, November 25, 2013 1:08 PM 
Key hep C protein revealed, paving the way for new vaccines 0 10385 Wednesday, December 4, 2013 7:57 AM 
Merck Unveils Interim Phase II Results 0 9321 Thursday, April 10, 2014 1:46 PM 
More Drugs Show Promise in Fighting Hepatitis C - HealthDay Article ThomasKim 0 11433 Thursday, August 15, 2013 11:36 AM 
Phase III Results for Gilead Hep C Combo 0 10333 Wednesday, December 18, 2013 12:51 PM 
Simeprevir Earns Positive Internal Review from FDA ThomasKim 0 10892 Tuesday, October 22, 2013 1:33 PM 
Spurred by pricey Gilead hep C drug, payers cook up new cost-control moves 0 10191 Monday, January 27, 2014 1:44 PM 

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site